Hepatectomy for Colorectal Metastases in the Presence of Extrahepatic Disease

Surgical Oncology Clinics of North America

Volumn 16, Issue 3, 2007, Pages 507-523

  Jaeck, Daniel ^a   Oussoultzoglou, Elie ^a   Rosso, Edoardo ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; OXALIPLATIN;

ADJUVANT THERAPY; COLORECTAL CANCER; HUMAN; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; LYMPH NODE METASTASIS; PERITONEUM CANCER; POSTOPERATIVE COMPLICATION; PROGNOSIS; QUALITY OF LIFE; REVIEW; SURVIVAL RATE;

CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; PROGNOSIS; RISK FACTORS;

EID: 34250902032     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.04.010     Document Type: Review

References (86)

1. Nordlinger B., Jaeck D., Guiguet M., et al. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: Nordlinger B., and Jaeck D. (Eds). Treatment of hepatic metastases of colorectal cancer (1992), Springer-Verlag, Paris 129-146
2. Minagawa M., Makuuchi M., Torzilli G., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231 4 (2000) 487-499
3. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 3 (1999) 309-318 [discussion: 318-21]
4. Adam R., Laurent A., Azoulay D., et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232 6 (2000) 777-785
5. Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 10 9 (2003) 1007-1011
6. Adam R., Pascal G., Azoulay D., et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238 6 (2003) 871-883 [discussion: 883-4]
7. Jaeck D., Oussoultzoglou E., Rosso E., et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240 6 (2004) 1037-1049 [discussion: 1049-51]
8. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 6 (2004) 818-825 [discussion: 825-7]
9. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 4 (2004) 644-657 [discussion: 657-8]
10. Simmonds P.C., Primrose J.N., Colquitt J.L., et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94 7 (2006) 982-999
11. Leonard G.D., Brenner B., and Kemeny N.E. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23 9 (2005) 2038-2048
12. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100 2 (1986) 278-284
13. Elias D., Benizri E., Pocard M., et al. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 32 6 (2006) 632-636
14. Sugarbaker P.H. Colorectal carcinomatosis: a new oncologic frontier. Curr Opin Oncol 17 4 (2005) 397-399
15. Koppe M.J., Boerman O.C., Oyen W.J., et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 243 2 (2006) 212-222
16. Fortner J.G., Silva J.S., Golbey R.B., et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199 3 (1984) 306-316
17. Ekberg H., Tranberg K.G., Andersson R., et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73 9 (1986) 727-731
18. Chang A.E., Schneider P.D., Sugarbaker P.H., et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206 6 (1987) 685-693
19. Hughes K.S., Rosenstein R.B., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 31 1 (1988) 1-4
20. Rosen C.B., Nagorney D.M., Taswell H.F., et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216 4 (1992) 493-504 [discussion: 504-5]
21. Gayowski T.J., Iwatsuki S., Madariaga J.R., et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116 4 (1994) 703-710 [discussion 710-1]
22. Elias D., Saric J., Jaeck D., et al. Prospective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 83 7 (1996) 942-945
23. Beckurts K.T., Holscher A.H., Thorban S., et al. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 84 8 (1997) 1081-1084
24. Ohlsson B., Stenram U., and Tranberg K.G. Resection of colorectal liver metastases: 25-year experience. World J Surg 22 3 (1998) 268-276 [discussion 276-7]
25. Iwatsuki S., Dvorchik I., Madariaga J.R., et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189 3 (1999) 291-299
26. Nakamura S., Suzuki S., and Konno H. Resection of hepatic metastases of colorectal carcinoma: 20 years' experience. J Hepatobiliary Pancreat Surg 6 1 (1999) 16-22
27. Kokudo N., Sato T., Seki M., et al. Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer. Dis Colon Rectum 42 10 (1999) 1285-1290 [discussion: 1290-1]
28. Harms J., Obst T., Thorban S., et al. The role of surgery in the treatment of liver metastases for colorectal cancer patients. Hepatogastroenterology 46 28 (1999) 2321-2328
29. Ambiru S., Miyazaki M., Isono T., et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 42 5 (1999) 632-639
30. Jaeck D., Nakano H., Bachellier P., et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol 9 5 (2002) 430-438
31. Ercolani G., Grazi G.L., Ravaioli M., et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 239 2 (2004) 202-209
32. Laurent C., Sa Cunha A., Rullier E., et al. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg 198 6 (2004) 884-891
33. Grobmyer S.R., Wang L., Gonen M., et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 244 2 (2006) 260-264
34. Tsavellas G., Patel H., and Allen-Mersh T.G. Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg 88 10 (2001) 1307-1320
35. Lindemann F., Schlimok G., Dirschedl P., et al. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340 8821 (1992) 685-689
36. Oberg A., Stenling R., Tavelin B., et al. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer?. Dis Colon Rectum 41 10 (1998) 1244-1249
37. Weitz J., Koch M., Kienle P., et al. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg 232 1 (2000) 66-72
38. Koch M., Kienle P., Hinz U., et al. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg 241 2 (2005) 199-205
39. Carmignani C.P., Ortega-Perez G., and Sugarbaker P.H. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol 30 4 (2004) 391-398
40. Moran B.J., and Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12 3 (2003) 585-603
41. Elias D., Blot F., El Otmany A., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 1 (2001) 71-76
42. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 20 (2003) 3737-3743
43. Yan T.D., Black D., Savady R., et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24 24 (2006) 4011-4019
44. Elias D., Ouellet J.F., Bellon N., et al. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90 5 (2003) 567-574
45. Begossi G., Gonzalez-Moreno S., Ortega-Perez G., et al. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma. Eur J Surg Oncol 28 1 (2002) 80-87
46. Abdalla E.K., Adam R., Bilchik A.J., et al. Improving resectablety of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13 10 (2006) 1271-1280
47. Jayne D.G., Fook S., Loi C., et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89 12 (2002) 1545-1550
48. August D.A., Sugarbaker P.H., and Schneider P.D. Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer 55 7 (1985) 1490-1494
49. August D.A. Metastases from metastasis. N J Med 93 7 (1996) 10
50. Kitagawa Y., Nagino M., Kamiya J., et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233 3 (2001) 385-392
51. Lin H.T., Liu G.J., Wu D., et al. Metastasis of primary gallbladder carcinoma in lymph node and liver. World J Gastroenterol 11 5 (2005) 748-751
52. Shimada H., Endo I., Togo S., et al. The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 79 5 (1997) 892-899
53. Kondo S., Nimura Y., Hayakawa N., et al. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg 87 4 (2000) 418-422
54. Araida T., Yoshikawa T., Azuma T., et al. Indications for pancreatoduodenectomy in patients undergoing lymphadenectomy for advanced gallbladder carcinoma. J Hepatobiliary Pancreat Surg 11 1 (2004) 45-49
55. Yasui K., and Kato T. A significance and indication of anatomical major hepatic resection of the liver metastases from colorectal cancer. [in Japanese]. Shoukaki Geka 16 (1993) 1693-1699
56. Nakamura S., Yokoi Y., Suzuki S., et al. Results of extensive surgery for liver metastases in colorectal carcinoma. Br J Surg 79 1 (1992) 35-38
57. Holm A., Bradley E., and Aldrete J.S. Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg 209 4 (1989) 428-434
58. Elias D.M., and Ouellet J.F. Incidence, distribution, and significance of hilar lymph node metastases in hepatic colorectal metastases. Surg Oncol Clin N Am 12 1 (2003) 221-229
59. Ishizaki N., Hamada N., Kadono J., et al. Obstructive jaundice caused by lymphatic remetastasis from the hepatic metastasis of rectosigmoid cancer. J Hepatobiliary Pancreat Surg 8 5 (2001) 469-472
60. Jaeck D., Bachellier P., Nakano H., et al. One- or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185 3 (2003) 221-229
61. Trutmann M., and Sasse D. The lymphatics of the liver. Anat Embryol (Berl) 190 3 (1994) 201-209
62. Ito M., Mishima Y., and Sato T. An anatomical study of the lymphatic drainage of the gallbladder. Surg Radiol Anat 13 2 (1991) 89-104
63. Sierzega M., Popiela T., Kulig J., et al. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 33 3 (2006) 240-245
64. Brister S.J., de Varennes B., Gordon P.H., et al. Contemporary operative management of pulmonary metastases of colorectal origin. Dis Colon Rectum 31 10 (1988) 786-792
65. McCormack P.M., Burt M.E., Bains M.S., et al. Lung resection for colorectal metastases. 10-year results. Arch Surg 127 12 (1992) 1403-1406
66. Shirouzu K., Isomoto H., Hayashi A., et al. Surgical treatment for patients with pulmonary metastases after resection of primary colorectal carcinoma. Cancer 76 3 (1995) 393-398
67. Inoue M., Ohta M., Iuchi K., et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 78 1 (2004) 238-244
68. Lee W.S., Yun S.H., Chun H.K., et al. Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis (2006) [Epub ahead of print]
69. Saito Y., Omiya H., Kohno K., et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 124 5 (2002) 1007-1013
70. Watanabe I., Arai T., Ono M., et al. Prognostic factors in resection of pulmonary metastasis from colorectal cancer. Br J Surg 90 11 (2003) 1436-1440
71. Yedibela S., Klein P., Feuchter K., et al. Surgical management of pulmonary metastases from colorectal cancer in 153 patients. Ann Surg Oncol 13 11 (2006) 1538-1544
72. Pfannschmidt J., Klode J., Muley T., et al. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg 81 2 (2006) 448-454
73. Mineo T.C., Ambrogi V., Tonini G., et al. Long-term results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 197 3 (2003) 386-391
74. Ogata Y., Matono K., Hayashi A., et al. Repeat pulmonary resection for isolated recurrent lung metastases yields results comparable to those after first pulmonary resection in colorectal cancer. World J Surg 29 3 (2005) 363-368
75. Ercan S., Nichols III F.C., Trastek V.F., et al. Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma. Ann Thorac Surg 77 5 (2004) 1786-1791
76. Murakami S., Terakado M., Hashimoto T., et al. Adrenal metastasis from rectal cancer: report of a case. Surg Today 33 2 (2003) 126-130
77. Cante D., Girelli G., La Porta M.R., et al. Late brain metastases from colorectal cancer: a case report and review of the literature. Tumori 91 3 (2005) 280-282
78. Kanjo T., Albertini M., and Weber S. Long-term disease-free survival after adrenalectomy for isolated colorectal metastases. Asian J Surg 29 4 (2006) 291-293
79. Gencosmanoglu R., Aker F., Kir G., et al. Isolated metachronous splenic metastasis from synchronous colon cancer. World J Surg Oncol (2006) [Epub ahead of print]
80. Simmonds P.C. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 321 7260 (2000) 531-535
81. Jonker D.J., Maroun J.A., and Kocha W. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials. Br J Cancer 82 11 (2000) 1789-1794
82. Adam R., Avisar E., Ariche A., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8 4 (2001) 347-353
83. Bismuth H., Adam R., Levi F., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224 4 (1996) 509-520 [discussion: 520-2]
84. Adam R., Huguet E., Azoulay D., et al. Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am 12 1 (2003) 211-220
85. Tanaka K., Adam R., Shimada H., et al. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90 8 (2003) 963-969
86. Elias D., Liberale G., Vernerey D., et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12 11 (2005) 900-909